Irwin Fritchie Returns Defense Verdict in Bellwether MDL


NEW ORLEANS, LA – On November 18, 2021, Douglas J. Moore, of Irwin Fritchie Urquhart & Moore, partnered with Hildy Sastre and Jon Strongman of Shook Hardy & Bacon to return a defense verdict on behalf of Sanofi Aventis US LLC in the second bellwether trial held in the In Re Taxotere  Products Liability Litigation, MDL No. 2740. At the culmination of a nearly two-week jury trial held in the Eastern District of Louisiana, a defense verdict was rendered on the first question on the verdict form, with the jury finding that Sanofi did not fail to adequately warn of the risk of permanent chemotherapy-induced alopecia associated with the use of Taxotere, a life-saving chemotherapy medication. This was the second bellwether trial in which defense verdict was returned in MDL 2740. The first case, also tried by Sastre, Strongman, and Moore, was a defense verdict where the jury also returned a verdict on the first question on verdict form – that time concluding that the Plaintiff failed to prove that she has permanent chemotherapy-induced alopecia caused by Taxotere.  

Related Professionals

Subscribe for Updates from Irwin Fritchie
Jump to Page

By using this site, you agree to our updated Privacy Policy and our Terms of Use.